uniQure Researchers Swap Out Lead Drug for a Better Prospect Post author:Sam Post published:October 18, 2017 Post category:BioPharma The company plans to expeditiously advance AMT-061 instead of AMT-060. Source: BioSpace You Might Also Like Novartis Oncology Head to Retire for Personal Reasons December 14, 2017 Zealand Pharma Increases Its Share Capital As A Consequence Of Exercise Of Employee Warrants May 29, 2017 79 Employees Affected as Novartis Plans Shut Down of UK Site December 4, 2017
Zealand Pharma Increases Its Share Capital As A Consequence Of Exercise Of Employee Warrants May 29, 2017
